130 related articles for article (PubMed ID: 26546940)
1. [Off-label use of oncology drugs: national survey results].
González-Haba Peña E; Agustín Ferrández MJ; Mangues Bafalluy I; Alfredo López N; Fraga Fuentes MD; Marín Gil R; Martínez Bautista MJ; Clopés Estela A
Farm Hosp; 2015 Sep; 39(5):275-87. PubMed ID: 26546940
[TBL] [Abstract][Full Text] [Related]
2. [Off-label approval of drug use in a tertiary hospital].
Pérez-Moreno MA; Villalba-Moreno AM; Santos-Ramos B; Marín-Gil R; Varela-Aguilar JM; Torelló-Iserte J; Núñez-Vázquez R; Jiménez-Jiménez J; Bautista-Paloma FJ
Rev Calid Asist; 2013; 28(1):12-8. PubMed ID: 22789731
[TBL] [Abstract][Full Text] [Related]
3. Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme.
Mellor JD; Van Koeverden P; Yip SW; Thakerar A; Kirsa SW; Michael M
Intern Med J; 2012 Nov; 42(11):1224-9. PubMed ID: 22372936
[TBL] [Abstract][Full Text] [Related]
4. Off-label use of anti-cancer drugs in India: to be or not to be!
Gota V; Patial P
J Cancer Res Ther; 2011; 7(1):35-9. PubMed ID: 21546740
[TBL] [Abstract][Full Text] [Related]
5. Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals.
Kurzrock R; Gurski LA; Carlson RW; Ettinger DS; Horwitz SM; Kumar SK; Million L; von Mehren M; Benson AB
Ann Oncol; 2019 Oct; 30(10):1647-1652. PubMed ID: 31373348
[TBL] [Abstract][Full Text] [Related]
6. Off-label drug use in oncology: a systematic review of literature.
Saiyed MM; Ong PS; Chew L
J Clin Pharm Ther; 2017 Jun; 42(3):251-258. PubMed ID: 28164359
[TBL] [Abstract][Full Text] [Related]
7. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
Kocs D; Fendrick AM
Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
[TBL] [Abstract][Full Text] [Related]
8. A uniform procedure for reimbursing the off-label use of antineoplastic drugs according to the value-for-money approach.
Messori A; Fadda V; Trippoli S
J Chemother; 2011 Apr; 23(2):67-70. PubMed ID: 21571620
[TBL] [Abstract][Full Text] [Related]
9. Off-label prescription of drugs at hospital.
Arocas Casañ V; Mateo Carmona J; García Molina O; Fernández de Palencia Espinosa MÁ; Blázquez Álvarez MJ; de la Rubia Nieto MA; del Río García J
Farm Hosp; 2016 Mar; 40(2):63-71. PubMed ID: 26980165
[TBL] [Abstract][Full Text] [Related]
10. Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.
Joerger M; Schaer-Thuer C; Koeberle D; Matter-Walstra K; Gibbons-Marsico J; Diem S; Thuerlimann B; Cerny T
Eur J Clin Pharmacol; 2014 Jun; 70(6):719-25. PubMed ID: 24609468
[TBL] [Abstract][Full Text] [Related]
11. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
12. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
13. Off-label drugs in palliative care: a Group Delphi treatment recommendation process.
Remi C; Weingärtner K; Hagemann V; Bausewein C; Hodiamont F
BMJ Support Palliat Care; 2021 Jun; 11(2):180-187. PubMed ID: 32398226
[TBL] [Abstract][Full Text] [Related]
14. [Results from the 2012-2013 paediatric national survey on off-label drug use in children in Spain (OL-PED study)].
Piñeiro Pérez R; Ruiz Antorán MB; Avendaño Solá C; Román Riechmann E; Cabrera García L; Cilleruelo Ortega MJ; Mellado Peña MJ
An Pediatr (Barc); 2014 Jul; 81(1):16-21. PubMed ID: 24286874
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of off-label use of oral oncolytics at a community cancer center.
Kalis JA; Pence SJ; Mancini RS; Zuckerman DS; Ineck JR
J Oncol Pract; 2015 Mar; 11(2):e139-43. PubMed ID: 25604593
[TBL] [Abstract][Full Text] [Related]
16. Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.
Shimazawa R; Ikeda M
Clin Ther; 2012 Oct; 34(10):2104-16. PubMed ID: 23036337
[TBL] [Abstract][Full Text] [Related]
17. [Pertinence of Off-label Prescriptions of Innovating and Expensive Drugs in a University Hospital].
Falabregues A; Daul M; Pourroy B; Gauthier-Villano L; Pisano P; Rathelot P; Vialettes B
Therapie; 2015; 70(5):385-402. PubMed ID: 26142399
[TBL] [Abstract][Full Text] [Related]
18. The ethics of off-label use of drugs: oncology pharmacy in Italy.
Bernardi A; Pegoraro R
J Clin Pharm Ther; 2008 Apr; 33(2):95-9. PubMed ID: 18315773
[TBL] [Abstract][Full Text] [Related]
19. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
20. Off-label prescribing patterns of antidepressants in children and adolescents.
Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
